Zhengye Biotechnology Holding (ZYBT) Debt to Equity (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Debt to Equity for 2 consecutive years, with $0.03 as the latest value for Q4 2024.
- Quarterly Debt to Equity fell 88.44% to $0.03 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $0.03 through Dec 2024, down 88.44% year-over-year, with the annual reading at $0.04 for FY2024, 85.42% down from the prior year.
- Debt to Equity for Q4 2024 was $0.03 at Zhengye Biotechnology Holding, down from $0.29 in the prior quarter.
- The five-year high for Debt to Equity was $0.29 in Q4 2023, with the low at $0.03 in Q4 2024.